Very-long-chain acyl-CoA dehydrogenase deficiency (VLCAD)


Very-long-chain acyl-CoA dehydrogenase deficiency (VLCAD) is a condition in which the body is unable to break down certain fats. It is considered a fatty acid oxidation condition because people affected by VLCAD are unable to convert some of the fats they eat into energy the body needs to function. Too many unused fatty acids build up in the body. If untreated, VLCAD can cause brain damage and even death. If the condition is detected early in life and proper treatment is begun, individuals with VLCAD often can lead healthy lives.

This condition is also known as: ACADVL, acyl-CoA dehydrogenase very long chain deficiency, very long-chain acyl coenzyme A dehydrogenase deficiency, VLCAD-C, VLCAD-H, LCAD.

To learn more information about Very-long-chain acyl-CoA dehydrogenase deficiency, visit Screening, Technology, and Research in Genetics (STAR-G): Very-long-chain acyl-CoA dehydrogenase deficiency and Baby's First Test: Very-long-chain acyl-CoA dehydrogenase deficiency. Please see Medically Prescribed Formula for information about medically prescribed formula and pharmacologic interventions for inborn errors of metabolism. Visit Board Certified Metabolic Providers (PDF: 2 pages/204KB) for a listing of medical specialists and clinic contact information.